Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 10/22/19

Staff, Pictures and Bios

Bhanu Ramineni, M.S., M.S., Branch Chief

Bhanu Ramineni, M.S., M.S., became the Branch Chief of the Regulatory Affairs Branch in October 2019. She joined the Drug Regulatory Group in the branch in 2010. She holds two Master's degrees: one in Environmental Sciences from Nagarjuna University, India, and a second one in Biochemistry and Molecular Biology with a specialization in Biotechnology from Georgetown University. More…

Jianqiao Zhang, PhD, Associate Chief, Agreement Coordination Group

In September 2019, Dr. Jianqiao Zhang was appointed as the new Associate Chief, Agreement Coordination Group in the Regulatory Affairs Branch, CTEP. Dr. Zhang received his PhD in Biochemistry from the University of Nottingham, UK. He did postdoctoral research on cancer biology before joining the Agreement Coordination Group, Regulatory Affairs Branch at CTEP. More…

Massimo Cardinali, M.D., Senior Regulatory Affairs Manager

Massimo Cardinali, M.D. joined the Drug Regulatory Group in the Regulatory Affairs Branch in 2014. Dr. Cardinali graduated from the Medical School of the University of Pisa, Italy, in 1984. In 1986, after completing his residency in the Nuclear Medicine Department of the University of Pisa, he moved to NIH to conduct basic research in Oncology. More…

Jason Denner, B.S., Regulatory Program Specialist, R&D Agreements

Jason Denner is a Regulatory Program Specialist in the Regulatory Affairs Branch. He has been working with RAB since 2003 and has also supported other programs within the division during that time. Jason earned his B.S. degree from the University of Baltimore with a major in Health Systems Management. More…

Linda Park, Pharm.D., M.S.

Dr. Linda Park joined the Drug Regulatory Group in the Regulatory Affairs Branch (RAB), CTEP in 2018. Prior to joining RAB, Dr. Park spent 8 years at FDA, , where she held a number of positions in the Center for Drug Evaluation and Research. More…

Julie Rhie, Ph.D., R.Ph., Pharmacologist, Senior Regulatory Affairs Scientist

Julie Rhie joined the Regulatory Affairs Branch in 2001. Her role within RAB includes acting as a regulatory liaison for CTEP with the FDA and as an internal regulatory policy advisor. More…

Karen Said, B.A., Executive Assistant

Karen Said joined the Regulatory Affairs Branch in March of 2012 and serves as the Executive Assistant and Office Manager. She attended Hampshire College in Amherst, MA and graduated with a B.A. degree in Liberal Arts and a concentration in Nutrition. More…

About the Branch Chief

Bhanu Ramineni, M.S., M.S. Bhanu Ramineni, M.S., M.S., became the Chief of the Regulatory Affairs Branch in October 2019. She joined the Drug Regulatory Group in the branch in 2010. She holds two Master's degrees: one in Environmental Sciences from Nagarjuna University, India, and a second one in Biochemistry and Molecular Biology with a specialization in Biotechnology from Georgetown University. Ms. Ramineni comes with significant experience in FDA Regulatory Affairs, as well as preclinical and clinical development of vaccines with a special focus in immunology. More…